Abstract
Background Preliminary studies have shown that the addition of the partial NMDA-agonist D-cycloserine (DCS) might be promising in enhancing the results of exposure therapy in obsessive-compulsive disorder (OCD). We examined the effect of DCS addition to exposure therapy in a somewhat larger sample of OCD patients with special attention to
... read more